Target intelligence / Profile preview

Heat shock transcription factor 2 (HSF2)

Target
HSF2
Molecular classification
Transcription factor, DNA-binding protein
01

Overview

Heat shock transcription factor 2 is a DNA-binding transcription factor that activates gene expression in response to various stresses—most notably proteotoxic and heat stress—by binding to specific DNA sequences known as heat shock promoter elements (HSE)[1][2][4]. HSF2 is part of the heat shock factor family in humans, along with HSF1 and HSF4, and plays essential roles in cellular adaptation to stress, development, and disease. In higher eukaryotes, HSF2 remains largely inactive under normal conditions and is activated primarily during stress or specific developmental contexts[1][2][3][4]. It regulates genes involved in protein folding, quality control, and cell protection; aberrant HSF2 function has been implicated in diseases such as cancer, neurodegenerative disorders, and certain forms of infertility and red blood cell cancers[2][3]. Unlike HSF1, direct pharmacological targeting of HSF2 is not well established, but its critical regulatory roles and disease associations make it a growing area of interest for therapeutic development.

Other names
HSF2Heat shock factor protein 2HSF-2
02

Mechanism of action

null (no established, clinically relevant drugs known to act directly on HSF2, so specific mechanisms for targeting drugs are undefined)

03

Biological functions

Transcriptional regulation of stress response genesRegulation of cellular response to heat shock and proteotoxic stressRegulation of developmentModulation of protein folding and quality controlRegulation of apoptosis
04

Disease associations

CancerNeurodegenerative diseaseProteopathiesSpermatogenic failureErythroleukemiaUlcerative colitis
05

Safety considerations

Potential effects on regulation of cell death and differentiation pathways if modulated systemicallyImpact on protein homeostasis and stress response, which could affect multiple organ systems
06

Interacting drugs

null (no direct drugs are currently referenced in standard databases or literature results for HSF2-specific targeting)
07

Biomarkers

null (no well-established clinical biomarker roles for HSF2 per current literature)

Beyond the preview

Go deeper on Heat shock transcription factor 2 (HSF2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heat shock transcription factor 2 (HSF2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call